B6.038 Metabolism of Purine and Pyrimidine Nucleotides Flashcards

1
Q

purines

A

adenine

guanine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pyrimidines

A

thymine (DNA)
cytosine
uracil (RNA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

starting substrate for de novo purine synthesis

A

ribose 5-P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

manifestations of gout in clinic

A

acute gouty arthritis

nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what causes symptoms of gout?

A

crystal deposition in joints and/or kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

urate crystal formation in urine

A

at low pH: uric acid predominates in urine and uric acid crystals precipitate (common)
at high pH: urate predominates and Na+ urate crystals precipitate (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

urate crystal formation in joints

A

urate predominates and Na+ urate crystals precipitate in synovial fluid and auricles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

who is most likely to develop gout?

A

adult men

95% are under-excreters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

diseases w associations w gout

A

hypertriglyceridemia
hypertension
metabolic syndrome
all related to obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

factors that lead to chronic urate underexcretion

A

decreased glomerular filtration in patients with renal failure
inhibition of excretion by organic acids (ketoacidosis, aspirin, excessive alcohol)
chronic dehydration
anything that can decrease amt of urine excreted in general

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

diagnosis of gout

A

aspirating fluid from affected joint and finding negatively birefringent crystals under polarizing microscope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

benefits of urate

A

normally in body @ 7-10% concentration
antioxidant properties
when this conc increases in when symptoms emerge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hyperuricemia

A

too much urate in blood
due to:
-urate overproduction
-under excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

chronic hyperuricemia

A

gout

  • acute arthritis
  • kidney stones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

where is ribose-5-p for purine synthesis derived from

A

pentose phosphate pathway

from glucose-6-p

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

general overview of de novo synthesis of ATP and GTP

A

ribose-5-P > PRPP > IMP > AMP or GMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

enzyme which converts ribose-5-p to PRPP

A

PRPP synthase

  • inhibited by ADP
  • activated by phosphate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

enzyme which converts PRPP to IMP

A

glutamine-PRPP amidotransferase

  • non-reversible
  • inhibited by AMP and GMP (feedback)
  • activated by PRPP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

molecules needed for conversion of PRPP to IMP

A

folate molecules (N10-formyl-THF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

mycophenolic acid in purine synthesis

A

inhibits conversion of IMP to GMP
acts as an immunosuppressant
reduces synthesis of DNA/RNA in lymphocytes (primary cells that utilize de novo purine synthesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

degradation of GMP

A

GMP > guanine > xanthine (taken up by liver) > urate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

degradation of AMP

A

AMP > hypoxanthine (taken up by liver) > urate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

salvage of GMP

A

guanine from GMP breakdown travels through blood to new cell

guanine > GMP

24
Q

salvage of AMP

A

hypoxanthine from AMP breakdown travels through blood to new cell
hypoxanthine > IMP > AMP

25
Q

what % of production of IMP is de novo?

A

3%

97% salvage

26
Q

how is salvage preferred over de novo synthesis?

A
enzyme controls
HGPRT (salvage enzyme)
-greater affinity for PRPP
-higher max activity
glut PRPP amidotransferase (rate limiting enzyme in de novo synthesis)
-cooperativity toward PRPP
-only active at high PRPP concentrations
27
Q

HGPRT activity in Lesch-Neyhan

A

<2% of normal activity

little ability to salvage

28
Q

enzyme used to degrade hypoxanthine to urate

A

xanthine dehydrogenase (oxidase)

29
Q

drug used to increase excretion of urate

A

probenecid

inhibits reuptake of urate

30
Q

lifestyle modifications in gout treatment

A
reduce purine load by avoiding liver, kidney, sweetbreads
limit sugar intake
limit ethanol (particularly beer)
31
Q

urate lowering drugs

A
xanthine dehydrogenase (oxidase) inhibitors
uricase (less common)
32
Q

xanthine dehydrogenase (oxidase) inhibitors

A

allopurinol

febuxostat

33
Q

lesch-nyhan syndrome

A
X-linked recessive
HGPRT deficiency
-recycle almost no hypoxanthine
-increased de novo synthesis
-increased urate production
34
Q

symptoms of lesch-nyhan syndrome

A

mental retardation
profound motor disability
self mutilation
gout

35
Q

what is UMP

A

uridine monophosphate

precursor for all pyrimidine nucleotides

36
Q

pyrimidine nucleotides in DNA

A

dCTP

dTTP

37
Q

pyrimidine nucleotides in RNA

A

UTP

CTP

38
Q

pyrimidine nucleotides in phospholipids

A

CTP

39
Q

pyrimidine nucleotides in glycogen

A

UTP

40
Q

where does pyrimidine synthesis occur

A

liver

dividing cells

41
Q

general process of UMP synthesis

A

PRPP + orotate > UMP > uridine

42
Q

synthesis for UTP and CTP from UMP

A

UMP + 2ATP > UTP

UTP + ATP + glutamine > CTP

43
Q

what is UTP used in

A

RNA

glycogen

44
Q

what is CTP used in

A

DNA
RNA
phospholipids

45
Q

reduction of ribonucleotides to deoxyribonucleotides

A

NTP (UDP,CDP,ADP, or GDP) > dNTP

enzyme: ribonucleoside diphosphate reductase

46
Q

inhibitors of ribonucleoside diphosphate reductase (ribonucleotide reductase)

A

hydroxyurea
gemcitabine
dATP
dUDP, dCDP, dADP, dGDP

47
Q

hydroxyurea mechanism

A

leads to a decreased rate of deoxyribonucleotide production

reduces a protein tyrosyl radical that is crucial for enzyme activity

48
Q

gemcitabine mechanism

A

leads to a decreased rate of deoxyribonucleotide production
2 mechanisms:
1. dephosphorylated inhibits enzyme irreversible
2. triphosphorylated is incorporated into DNA and chain terminates

49
Q

synthesis of dTTP

A

dUMP > dTMP
enzyme: thymidylate synthase
enzyme 2: dihydrofolate reductase regenerates THF for reaction

50
Q

what is clinically significant about the synthesis of dTTP

A

DNA replication and repair are the only processes that depend on production of dTTP
-persons who are folate deficient do not make enough dTTP (not as big of an issue in AMP and GMP bc of the possibility of salvage)

51
Q

what happens if you deprive cells of dTTP

A

inhibit tumor synthesis
5-FU and premetrexed inhibit thymidylate synthase
MTX inhibits reduction of DHF to THF

52
Q

how does 5-FU inhibit dTTP synthesis

A

integrates into the molecule and acts as a suicide substrate

53
Q

drugs metabolized into 5-FU

A

capecitabine

tegafur

54
Q

mechanism of pemetrexed

A

inhibits thymidylate synthase directly

55
Q

mechanism of MTX

A

competitive inhibitor with a similar structure of DHF

56
Q

breakdown of UMP

A

liver dephosphorylates UMP to uridine
in the blood, uridine is salvaged and re-phosphorylated to UMP
-CTP made from UTP
-dTMP synthesis requires thymidylate synthase and DHF reductase

57
Q

result of RNA and DNA degradation

A

break down into pyrimidine mononucleotides that can be re-phosphorylated and reused